Covid 19 Sputnik V Vaccine. How It Is Different from Covaxin and Covishield

Covid 19 Sputnik V Vaccine. How It Is Different from Covaxin and Covishield

  • Home
  • -
  • Blog
  • -
  • Covid 19 Sputnik V Vaccine. How It Is Different from Covaxin and Covishield
Covid 19 Sputnik V Vaccine. How It Is Different from Covaxin and Covishield

Sputnik V is a two-dose Covid-19 vaccine. It is developed by the popular Gamaleya Research Institute of Epidemiology and Microbiology in Moscow. It is prepared using a similar platform to Covishield which is the most widely used vaccine in India since the beginning of the government’s immunisation programme. Yet, unlike Covishield, which uses a weakened common cold “adenovirus”, as far as Sputnik V is concerned, it makes use of two different human adenoviruses

If we compare it with Covaxin vs. Covishield vaccine, the vaccine has an efficacy of over 91 per cent. This suggests that it has the ability to bring down symptomatic Covid-19 cases by over 91 percent in those vaccinated compared with those who have not received a Covid vaccine.

Where Was Sputnik V Launched in India?

If we talk about the launch of Covid 19 Sputnik V Vaccine, following clearances from the Central Drugs Laboratory which performed various tests on the vaccine’s quality and stability, the primary dose of Sputnik V was successfully administered in Hyderabad.

As mentioned above, it uses a cold-type virus, engineered to be harmless, as a carrier to deliver a small fragment of the coronavirus to the body. After receiving the vaccination, the body starts to produce antibodies especially tailored to the virus.

Sputnik V has been approved for use in various countries. This includes Argentina, Venezuela, Hungary, UAE and Iran. This vaccine can be well stored at temperatures of between 2 and 8C degrees , thus, making it easier to transport and store.

How Many Doses will Sputnik Add to Vaccination Efforts in India?

At present, DRL has only received 150,000 doses of Sputnik V vaccine from Russia. India is expected to get at least 250 million doses, which will be sufficient to inoculate 125 million people, according to its agreement with the Russian Direct Investment Fund (RDIF).

Covaxin vs.Covishield vs. Sputnik Which Is Better?

Covaxin vs.Covishield vs. Sputnik V

Covishield is cheaper than Sputnik V at the moment. It is provided to most of the states at Rs 300 per dose. But, it is priced at Rs 600 per dose to the private hospitals. The Sputnik vaccine has been priced at Rs 948 per dose. However, the price of this vaccine goes up to Rs 995.40 per dose with the GST. And, Covaxin is the most expensive Covid-19 vaccine in India’s portfolio of vaccines so far. It is currently priced at Rs 400 per dose for the states. And, it is sold at Rs 1,200 per dose to private hospitals.

If we discuss about the Covaxin vs. Covishield vs. Sputnik efficacy rate, the effectiveness of Covaxin is 81% while the efficacy of Covishield is 90% and that of Sputnik is reported to be 91.6%.

The Sputnik jab uses two slightly different versions of the vaccine for the first and the second dose – given 21 days apart, unlike other vaccines. Both the jabs target the coronavirus’s distinctive spike but use different vectors. And, it is important to take essential precautions after taking COVID vaccine.

Summing up:-

According to the reports, India has so far given over 200 million doses of Covishield, Covaxin and Sputnik V. And, approval has also been granted to Cipla to import Moderna vaccine, which has shown nearly 95% efficacy against COVID-19.The government targets to vaccinate all the Indians by the end of this year to stop the spread of the disease and save lives.

You may consult the doctors at the Sri Sri Holistic Hospitals

For more information regarding the COVID vaccine and you can also book Covid vaccination in Hyderabad.

Leave a Reply

Your email address will not be published. Required fields are marked *